Cataracts are the leading cause of blindness in adults older than age 50 worldwide.The global prevalence of cataracts has ...

Late last year, it launched its cell therapy Vyznova (neltependocel) in Japan to treat bullous keratopathy of the cornea. This is the first medicine of its kind to address corneal endothelial disease.

What is Beqvez for hemophilia? Beqvez (fidanacogene elaparvovec-dzkt), previously known as SPK-9001 or PF-06838435, was a gene therapy approved in the U.S. to treat certain adults with moderate to ...

It’s a painless procedure. Your specialist may apply drops containing a yellow dye to make the surface of your cornea more visible. Episcleritis is the most common eye-related symptom of Crohn ...

ntu.edu.tw Aim This study aimed to test whether human platelet lysate (HPL) has neurotrophic ability for corneal nerve regeneration. Methods We measured the neurotrophic factors in human peripheral ...

Novel stem cell therapy repairs 'irreversible' corneal damage in clinical trial Date: March 4, 2025 Source: Mass Eye and Ear Summary: Results from a phase 1/2 clinical trial of a novel stem cell ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. However, severe injuries, such as those caused by chemical burns or infections ...

Please provide your email address to receive an email when new articles are posted on . Allogenic corneal inlays are highly biocompatible and easy to implant. They offer a simple, safe solution ...

Advancements in corneal healing research are paving the way for innovative treatments for rare eye diseases, which are known to be a leading cause of irreversible blindness across Europe. A dedicated ...

Results also showed significant improvements in corneal staining and tear production, with effects observed as early as week 4 and maintained through week 12. Patients reported reduced reliance on ...